Log in to search using one of your social media accounts:

 

Artificial Intelligence May Transform Retinal Screening Artificial Intelligence May Transform Retinal Screening
The new technology is a potential breakthrough for diabetic retinopathy screening, but is not without risks.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2017 Category: Consumer Health News Tags: Ophthalmology Commentary Source Type: news

Retinal surgeon expands practice while serving Native American communities and third-world countries
Retinal surgeon expands practice. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 18, 2017 Category: American Health Authors: Angela Gonzales Source Type: news

Ganglion Cell Loss May Trigger Retinal Problems in Congenital Zika Syndrome Ganglion Cell Loss May Trigger Retinal Problems in Congenital Zika Syndrome
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

The effect of vitamin A on fracture risk: a meta-analysis of cohort studies - Zhang X, Zhang R, Moore JB, Wang Y, Yan H, Wu Y, Tan A, Fu J, Shen Z, Qin G, Li R, Chen G.
This meta-analysis evaluated the influence of dietary intake and blood level of vitamin A (total vitamin A, retinol or β-carotene) on total and hip fracture risk. Cohort studies published before July 2017 were selected through English-language literature ... (Source: SafetyLit)
Source: SafetyLit - September 14, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Eye changes may signal frontotemporal lobe degeneration
(University of Pennsylvania School of Medicine) Frontotemporal degeneration (FTD) is a progressive neurodegenerative condition that is present in tens of thousands of Americans, but is often difficult to diagnose accurately. Now in a study published this week online ahead of print in Neurology, researchers from the Perelman School of Medicine at the University of Pennsylvania have found evidence that a simple eye exam and retinal imaging test may help improve that accuracy. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Google ’ s Verily is developing AI-powered heart disease test using retinal images
Google (NSDQ:GOOG) parent Alphabet‘s (NSDQ:GOOGL) Verily is developing a new artificial-intelligence powered test that searches for indicators of heart disease risk present in retina images, according to a new study. The study, which has not yet been peer reviewed but has been published by Cornell University, details a new machine-learning powered system designed by Verily to “discover new knowledge from retinal fundus images.” The system operates on data from 284,335 patients, validated on 2 independent datasets of 12,026 and 999 patients, to predict cardiovascular risks “not previously t...
Source: Mass Device - September 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Imaging Optical/Ophthalmic Research & Development Alphabet Inc. Google Inc. Verily Source Type: news

Prevent vitamin A and iron deficiency - multivitamins ARE better than diet alone
MULTIVITAMINS are better than diet alone in preventing vitamin and mineral deficiency - a new study has found. (Source: Daily Express - Health)
Source: Daily Express - Health - August 31, 2017 Category: Consumer Health News Source Type: news

FDA approved "Bionic Man" retinal implant to treat certain types of blindness... but there's no spy vision capability (yet)
(Natural News) The FDA has just granted approval to Second Sight Medical Products to embark on a human clinical study of its newest visual prosthesis system. Known as Orion, the device is a newer iteration of the Sylmar, California-based company’s successful Argus II retinal implant product. The Argus II gained approval in 2013, and it... (Source: NaturalNews.com)
Source: NaturalNews.com - August 30, 2017 Category: Consumer Health News Source Type: news

Retinal Imaging Device May Offer Insight Into Alzheimer's Retinal Imaging Device May Offer Insight Into Alzheimer's
A noninvasive retinal imaging device that detects changes in the eye that are indicative of brain amyloid may provide new insight into Alzheimer's disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

FDA clears Second Sight IDE trial of next-gen Orion cortical visual prosthesis
Second Sight Medical (NSDQ:EYES) said today it won FDA investigational device exemption to initiate a feasibility clinical study of its Orion cortical visual prosthesis system. The conditional approval gives the Sylmar, Calif.-based company clearance to enroll up to 5 patients at 2 US sites, but requires that the company conduct additional device testing and “address outstanding questions” within 45 days, it said. “This is an exciting milestone for the company given the potential of Orion to provide useful vision to millions of blind individuals worldwide who have no other option today. We are deligh...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Prosthetics second-sight-medical Source Type: news

Researchers unlock regenerative potential of cells in the mouse retina
(NIH/National Eye Institute) Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye's circuitry, new research shows. The findings potentially open the door to new treatments for eye trauma and retinal disease. The study appears in the July 26 issue of Nature, and was funded in part by the National Eye Institute, part of the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

New retinal imaging tech promises to help diagnose Alzheimers
New technology, developed by NeuroVision Imaging and Cedars-Sinai, is exploring the use of noninvasive eye imaging to detect Alzheimers disease, scanning the retina to identify protein deposits associated with the disorder. The system is designed to look for neurotoxic beta-amyloid protein deposits, which are also found in the brain in Alzheimers patients. Normally, such deposits are found through the use of positron emission tomography, or through the analysis of cerebrospinal fluid, both of which are invasive and costly, researchers said. Read the whole story on our sister site, Medical Design & Outsourcing The post ...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Imaging Research & Development NeuroVision Source Type: news

Retinal imaging may spot Alzheimer's disease early
Researchers from optical imaging technology firm NeuroVision Imaging and Cedars-Sinai...Read more on AuntMinnie.comRelated Reading: Retinal imaging device may detect early Alzheimer's (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 22, 2017 Category: Radiology Source Type: news

Clinical study shows that retinal imaging may detect signs of Alzheimer's disease
(Public Relations Pacific LLC) A study led by researchers at Cedars-Sinai and NeuroVision Imaging LLC provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer's. The experimental technology, developed by Cedars-Sinai and NeuroVision, scans the retina using techniques that can identify beta-amyloid protein deposits that mirror those in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2017 Category: International Medicine & Public Health Source Type: news

Noninvasive retinal imaging may improve early detection of Alzheimer's disease
(JCI Journals) In this issue of JCI Insight, researchers at Cedars-Sinai Medical Center adapted a noninvasive retinal imaging approach to characterize amyloid-β deposition, the pathological hallmark of Alzheimer's disease, in the retinas of patients and healthy controls. This imaging enabled detection and quantification of amyloid-β, revealing increased deposits in Alzheimer's patients compared to controls. These results demonstrate the feasibility of this approach as a tool for earlier Alzheimer's diagnosis and intervention. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 17, 2017 Category: International Medicine & Public Health Source Type: news

DRIL Predicts Future Visual Impairment in VO-ME Patients
(MedPage Today) -- Change in retinal layer disorganization corresponded to change in visual acuity (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - August 16, 2017 Category: General Medicine Source Type: news

Pneumatic Retinopexy Bests Vitrectomy As Retinal Detachment Tx
(MedPage Today) -- Office-based procedure offered better visual acuity scores at 1 year (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - August 15, 2017 Category: Opthalmology Source Type: news

BioTime lands $2m for dry-AMD therapy
BioTime Inc. (NYSE:BTX) said today that its subsidiary, Cell Cure Neurosciences, has landed a $2 million grant from the Israel Innovation Authority for the development of its dry-AMD therapy, OpRegen. The Alameda, Calif.-based company’s OpRegen is an investigational therapy that delivers retinal pigment epithelial cells into the subretinal space to replace lost RPE cells. Get the full story at our sister site, Drug Delivery Business News. The post BioTime lands $2m for dry-AMD therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Optical/Ophthalmic Pharmaceuticals Wall Street Beat BioTime Source Type: news

Vitamin B3 found in Marmite not proven to prevent miscarriage
Conclusion This early-stage laboratory research has pinpointed two potential genes that might be responsible for some miscarriages and birth defects. As well as identifying a problem, the researchers also managed to find a solution: the effect of these genes can be combatted by increasing vitamin B3 intake. But treating a very specific and uncommon cause of birth defects in mice is certainly not a sure-fire solution to "significantly reduce the number of miscarriages and birth defects around the world". We need future research to see if the same effect would happen in humans. Also, three of the four children inc...
Source: NHS News Feed - August 10, 2017 Category: Consumer Health News Tags: Pregnancy/child Source Type: news

Allegro ’ s diabetic macular edema trial meets primary endpoint
Privately-held biotech Allegro Ophthalmics said today that its Del Mar Phase IIb stage 2 trial met its primary endpoint. The study assessed Luminate as a sequential therapy or combo therapy in 80 patients with diabetic macular edema. The San Juan Capistrano, Calif.-based company’s Luminate integrin peptide therapy treats neovascular retinal diseases by targeting integrin receptors, which are involved in cell signaling, regulation and in building new blood vessels. Get the full story at our sister site, Drug Delivery Business News. The post Allegro’s diabetic macular edema trial meets primary endpoint ...
Source: Mass Device - August 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diabetes Drug-Device Combinations Optical/Ophthalmic Pharmaceuticals Wall Street Beat allegroophthalmics Source Type: news

Progress in Diabetic Retinopathy in the Spotlight at ASRS Progress in Diabetic Retinopathy in the Spotlight at ASRS
Treatments for diabetic retinopathy with new mechanisms of action will be generating interest at the upcoming American Society of Retinal Specialists (ASRS) Annual Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Regenerating retinal cells in mice
Researchers coaxed cells in an injured mouse eye into regenerating neurons that integrate into the eye ’s circuitry. The findings may open the door to new treatments for eye damage and disease. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - August 8, 2017 Category: Consumer Health News Source Type: news

View the Eclipse Safely with These Expert Tips
Treatment TermsEye careRetinal disease Author Sarah Avery Overview As excitement about the Aug. 21 solar eclipse builds, it ’s important to know how to safely view the event and understand how even everyday exposure to the sun can damage vision. Duke retina specialist and ophthalmologist Lejla Vajzovic from the Duke Eye Center shares her insights. Content Blocks Header How does the sun damage eyes? ContentAnytime you stare at the sun, you risk damaging your eyes, because the sun causes a physical burn at the back of the eye. The retina is essentially an extension of the brain, and it ’s made up of very ...
Source: dukehealth.org: Duke Health News - August 4, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news

Should We WAVE Goodbye to Laser? Should We WAVE Goodbye to Laser?
This study helps answer a common clinical question as to whether peripheral laser to areas of retinal ischemia improves vision and reduces injection burden in patients with retinal vein occlusion.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 1, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Taking vitamin supplements may slow down the progression of a common eye disease
Latest evidence published in the Cochrane Library suggests that taking a multivitamin supplement that includes vitamin E, carotenoids (beta-carotene or lutein or zeaxanthin), vitamin C, and zinc may slow down the progression of the common eye disease age-related macular degeneration (AMD).See additional resources at the bottom of the pageAge-related macular degeneration (AMD) is a progressive and sight-threatening disease affecting the central area of the retina and affects large numbers of people across the world. Population-based studies suggest that in older people (80 years and older), approximately one in three people...
Source: Cochrane News and Events - July 31, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Taking vitamin supplements will not prevent a common eye disease
Latest evidence published in the Cochrane Library suggests that taking vitamin supplements, such as vitamin E or beta-carotene, may not prevent the common eye disease age-related macular degeneration (AMD).  See additional resources at the bottom of this pageAge-related macular degeneration (AMD) is a progressive and sight-threatening disease affecting the central area of the retina and affects large numbers of people across the world. Population-based studies suggest that in older people (80 years and older), approximately one in three people have early signs of the disease.There are numerous unanswered questions in ...
Source: Cochrane News and Events - July 31, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Aerie inks deal for implantable drug-delivery system
Aerie Pharmaceuticals (NSDQ:AERI) said today that it inked a collaborative R&D and licensing agreement with DSM to develop an implantable drug-delivery system for patients with glaucoma and other retinal diseases. DSM has reportedly developed an injectable drug-delivery fiber using polyesteramide polymers that has proven successful in preclinical work with Aerie’s compounds. Get the full story at our sister site, Drug Delivery Business News.   The post Aerie inks deal for implantable drug-delivery system appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Optical/Ophthalmic Pharmaceuticals Wall Street Beat Aerie Pharmaceuticals dsm Source Type: news

Supplement warning: Overdosing on this vitamin can cause bone fractures
SUPPLEMENTS can help you top up on particular vitamins. However, taking vitamin A if you consume lots of liver or pate can place you at risk of osteoporosis and bone fractures. (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2017 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: July 28, 2017
[Image from unsplash.com]From Accenture’s AI-powered app to help the visually impaired to Rayovac getting clearance from Health Canada, here are seven medtech stories we missed this week but still thought were worth mentioning. 1. Accenture touts AI-powered app for visually impaired Accenture announced in a July 28 press release that it has developed an artificial intelligence–powered way to help the visually impaired experience their surroundings. The method involves a program called Drishti that is a smartphone-based assistant that uses AI technology like image recognition, natural language processing an...
Source: Mass Device - July 28, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) Regulatory/Compliance Spinal Surgical 4WEB Medical Accenture AGFA Healthcare Cogstate MedTech Orofacial Therapeutics Quantel Medical Rayovac Source Type: news

Vancomycin-Associated HORV:'Devastating Condition'Vancomycin-Associated HORV:'Devastating Condition '
Join in as two ophthalmologists have an in-depth discussion about vancomycin-associated hemorrhagic occlusive retinal vasculitis, including its diagnosis, treatment, and prognosis.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2017 Category: Consumer Health News Tags: Ophthalmology Commentary Source Type: news

Simulations signal early success for fractal-based retinal implants
(University of Oregon) Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2017 Category: International Medicine & Public Health Source Type: news

Second Sight Medical enters Russian market
Second Sight Medical (NSDQ:EYES) said today it entered the Russian market, with the 1st patient treated with its Argus II Retinal Prosthesis System in Moscow. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the Sylmar, Calif.-based company said. The 1st implant was performed at the Federal State Institution & Clinical Research Center of the Federal Medico-Biological Agency at the end of June 2017 by a team of surgeons, with Dr. Paulo Stanga ...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic second-sight-medical Source Type: news

Researchers unlock regenerative potential of cells in the mouse retina
NEI-funded researchers use a clue from zebrafish to discover the cues that reprogram M üller glia into retinal neurons. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 26, 2017 Category: American Health Source Type: news

7 medtech stories we missed this week: July 21, 2017
[Image from unsplash.com]From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two patients with its Argus II Retinal Prosthesis System in Seoul. The implants were made possible by the country’s distribution partner Kisantech Co. 2. K2M touts Japan distribution deal with Mitsubishi K2M signed a new, long-term exclusive a...
Source: Mass Device - July 21, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Regenerative Medicine Regulatory/Compliance Robotics Spinal Surgical Alpha Tau Medical Apifix Hill-Rom Holdings Inc. K2M Mitsubishi Reha Source Type: news

The effect of vitamin  D and calcium supplementation on falls in older adults : a systematic review and meta-analysis - Wu H, Pang Q.
OBJECTIVES: A  number of studies have hypothesized that vitamin D is a potential factor in the prevention of falls in the elderly; however, the effect of vitamin D is still inconsistent and not quantitative. We conducted this meta-analysis to assess the ... (Source: SafetyLit)
Source: SafetyLit - July 21, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

On the path to vitamin A in rice
(University of Freiburg) Biochemists from the University of Freiburg have elucidated the structure of an enzyme that supplies carotenoid. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 21, 2017 Category: Biology Source Type: news

Using omega 3 fatty acids to treat Alzheimer's & other diseases?
(Louisiana State University Health Sciences Center) Understanding how dietary essential fatty acids work may lead to effective treatments for diseases and conditions such as stroke, Alzheimer's disease, age-related macular degeneration, Parkinson's disease and other retinal and neurodegenerative diseases. The key is to be able to intervene during the early stages of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 18, 2017 Category: International Medicine & Public Health Source Type: news

FDA accepts for priority review Spark Therapeutics' gene therapy for blindness
The gene therapy targets an inherited retinal disease that leads to blindness. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 17, 2017 Category: American Health Authors: John George Source Type: news

Spark Therapeutics announces publication in The Lancet of pivotal Phase 3 clinical trial data for investigational voretigene neparvovec
(Ten Bridge Communications) Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced The Lancet, a highly ranked peer-reviewed journal, has published Phase 3 clinical trial data of voretigene neparvovec, an investigational, potential one-time gene therapy candidate for the treatment of patients with vision loss due to confirmed biallelic RPE65-mediated inherited retinal disease (IRD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 14, 2017 Category: International Medicine & Public Health Source Type: news

Newly discovered elovanoids called a 'transformative new concept of biology'
(Louisiana State University Health Sciences Center) Research led by Nicolas Bazan, M.D., Ph.D., Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of mediators, or biochemical triggers that he named elovanoids (ELVs). This discovery provides the first evidence of the existence of elovanoids and of their significant role in protecting and sustaining retinal pigment epithelial (RPE) and photoreceptor cell survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2017 Category: International Medicine & Public Health Source Type: news

New Human RPES and BMSCS
NeedHuman Cells? Just Ask!This is our cornerstone and we keep building on it. You asked for them. We are pleased to announce we now haveHuman Bone Marrow-Derived Stem Cells (BMSCs) andRetinal Pigment Epithelial Cells (RPES).RPES in Culture.BMSCS in Culture.We will continue to post new cell offerings here. (Source: Neuromics)
Source: Neuromics - July 11, 2017 Category: Neuroscience Tags: BMSCs Bone marrow derived stem cells Human Mesenchymal Stem Cells Retinal Pigment Epithelial Cells RPES Source Type: news

How Adaptive Optics Will Change Retinal Imaging
(MedPage Today) -- Technology could allow cell-by-cell monitoring of retinal diseases (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - July 10, 2017 Category: Opthalmology Source Type: news

QUT develops golden bananas high in pro-vitamin A
(Queensland University of Technology) QUT has produced Ugandan bananas high in pro-vitamin A.Cooking bananas are the staple food in rural UgandaWorldwide 650 000 - 750 000 children die from vitamin A deficiency.Ugandan farmers will be growing pro-vitamin A rich bananas in 2021.A humanitarian project backed by the Bill& Melinda Gates Foundation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2017 Category: International Medicine & Public Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for July 3, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. BD extends Bard note exchange offering again Becton Dickinson said today is once again extending its exchange offering for up to $1.1 billion in outstanding C. R. Bard notes from July 3 to August 1. The company is offering exch...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Second Sight Medical wins expanded CMS coverage for Argus II
Second Sight Medical (NSDQ:EYES) said today its Argus II retinal prosthesis system won expanded reimbursement coverage from the Centers for Medicare and Medicaid Services in 11 additional states and the District of Columbia. With the expansion, the Sylmar, Calif.-based company said it’s Argus II device is now reimbursable in 7 of the 12 Medicare Administrative Contractor jurisdictions, covering the device in a total of 28 states, 2 territories and D.C. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulse...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic second-sight-medical Source Type: news

Nigeria: Low Levels of Vitamin A May Fuel TB Risk
[Guardian] People with low levels of vitamin A living with individuals sick with tuberculosis may be 10 times more likely to develop the disease than people with high levels of the nutrient, according to research led by investigators at Harvard Medical School, United States (U.S.). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 16, 2017 Category: African Health Source Type: news

Medical News Today: Could lack of vitamin A be a cause of diabetes?
Researchers have found that insulin-producing beta cells in the pancreas contain vitamin A receptors, and that blocking them reduces insulin secretion. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 14, 2017 Category: Consumer Health News Tags: Diabetes Source Type: news

Low levels of vitamin A may fuel TB risk
(Harvard Medical School) People with low levels of vitamin A living with individuals sick with tuberculosis may be 10 times more likely to develop the disease than people with high levels of the nutrient, according to research led by investigators at Harvard Medical School. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2017 Category: International Medicine & Public Health Source Type: news

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
Vitamin A deficiency (VAD) is a major public health problem in low- and middle-income countries, affecting 190 million children under five years of age and leading to many adverse health consequences, including death. Based on prior evidence and a previous version of this review, the World Health Organization has continued to recommend vitamin A supplementation for children aged 6 to 59 months. There are new data available from recently published randomised trials since the previous publication of this review in 2010, and this update incorporates this information and reviews the evidence. To assess the effects of vitamin...
Source: Current Awareness Service for Health (CASH) - May 22, 2017 Category: Consumer Health News Source Type: news